VPM-p15 is a protease-sensitive peptide designed for controlled degradation in biomaterial systems. Its sequence incorporates residues that modulate susceptibility to matrix metalloproteinases. Researchers study cleavage kinetics and structural stability within engineered matrices. Applications include responsive hydrogel design, targeted-release systems, and biomaterial functionalization.
VPM-p15 is a synthetic peptide that has garnered significant interest within the field of immunology and vaccine research due to its unique sequence and functional properties. As a peptide fragment derived from the VPM (Vesicular stomatitis virus glycoprotein, Pseudomonas aeruginosa, and Mycobacterium tuberculosis) platform, VPM-p15 is engineered to mimic specific antigenic regions, making it a valuable tool for probing immune responses and studying antigen presentation mechanisms. Its defined structure and biochemical stability enable researchers to investigate peptide-MHC interactions, T-cell activation pathways, and the development of peptide-based immunotherapeutics. The compound's versatility and reproducibility make it a preferred choice for a wide range of experimental applications in both basic and applied peptide research.
Epitope mapping: VPM-p15 is extensively utilized in epitope mapping studies to identify and characterize T-cell epitopes involved in specific immune responses. By incorporating this peptide into in vitro assays, scientists can systematically analyze the recognition patterns of T cells and determine the immunodominant regions within larger antigenic proteins. This approach is crucial for dissecting the molecular basis of antigen recognition and for guiding the rational design of next-generation peptide vaccines and immunomodulators.
Antigen presentation assays: The peptide serves as an ideal substrate in antigen presentation experiments, particularly for assessing the processing and presentation of exogenous peptides by major histocompatibility complex (MHC) molecules. Its defined sequence allows for precise evaluation of peptide loading onto MHC class I or class II molecules, facilitating studies on antigen processing pathways and the efficiency of peptide delivery systems. Such investigations are instrumental in optimizing vaccine formulations and enhancing antigen-specific immune responses.
T-cell activation studies: VPM-p15 is frequently employed in functional assays designed to measure T-cell activation, proliferation, and cytokine production in response to specific peptide antigens. By exposing peripheral blood mononuclear cells or isolated T-cell populations to this peptide, researchers can assess the specificity and magnitude of cellular immune responses. These experiments are essential for evaluating the immunogenicity of candidate vaccine components and for elucidating the mechanisms underlying T-cell mediated immunity.
Peptide-MHC binding affinity analysis: The compound is a valuable reagent in binding affinity assays aimed at quantifying the interaction between peptides and MHC molecules. Techniques such as competitive binding assays, surface plasmon resonance, or ELISA-based formats utilize VPM-p15 to determine binding kinetics, stability, and specificity. Data generated from these studies inform the selection of optimal peptide candidates for vaccine development and immunotherapy research by identifying sequences with high MHC affinity and favorable immunological properties.
Peptide-based assay development: VPM-p15 is incorporated into the development of peptide-based diagnostic and screening assays to detect antigen-specific T-cell responses or to evaluate the efficacy of immunization protocols. Its well-characterized sequence and reproducibility support the standardization of assay conditions, enabling consistent and reliable measurement of immune parameters across experimental platforms. Such applications contribute to the advancement of translational research in immunology, vaccine discovery, and the assessment of novel adjuvant systems.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More